Stay updated on Phase 1b Micellar Docetaxel in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.

Latest updates to the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the docetaxel micellar trial in metastatic castration-resistant prostate cancer is displayed, with study details and its terminated status.SummaryDifference44%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study page remains inaccessible with a 403 error.SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page remains a 403 Forbidden error page; the footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedA new Revision: v3.7.0 tag appears, and several historical metadata sections and navigation items were removed to streamline the page.SummaryDifference18%

Stay in the know with updates to Phase 1b Micellar Docetaxel in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.